Study Identifies 74 Human Genome Locations Linked to Anxiety Symptoms

IMT News Desk
IMT News Desk
· 1 min read
A major study identifies 74 human genome locations linked to anxiety symptoms, including 39 new findings, in the largest analysis of its kind.

Scientists have identified 74 locations in the human genome linked to anxiety symptoms, with 39 of them newly discovered in the latest large-scale study. The research, involving more than 690,000 people, marks the largest number of anxiety-related genetic associations reported so far.

The findings suggest that anxiety is influenced by many genetic factors rather than a single gene, reinforcing the idea that the condition is biologically complex. Researchers also said the results point to a mix of genetic and environmental influences, with life experiences continuing to play an important role in how anxiety develops.

Megan Skelton, research fellow at King’s College London and the study’s first author, said the team’s findings help improve understanding of how anxiety symptoms may arise at a biological level. The study also highlights why prevention and treatment approaches need to account for both inherited risk and environmental triggers.

The researchers said the newly identified regions may help guide future work on the biology of anxiety and could eventually support more targeted treatment strategies. They added that the results strengthen evidence that anxiety shares genetic links with other mental health conditions and related traits.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk